Related Experiment Video
Updated: Oct 2, 2025

Discovery of New Intracellular Pathogens by Amoebal Coculture and Amoebal Enrichment Approaches
Published on: October 27, 2013
Social amoebae as a new chassis for drug production
Vincent Courdavault1, Nicolas Papon2
1Biomolécules et Biotechnologies Végétales, BBV, EA2106, Université de Tours, Tours, France.
Abstract:
Engineered bacteria and yeasts have progressively emerged in the past decade as convenient cell factories for supplying plant and fungal natural products (NPs). A new study by Reimer et al. provides compelling evidence that the amoeba Dictyostelium discoideum could be also engineered in favor of the production of plant drug precursors.
More Related Videos
07:33Author Spotlight: Studying Behavior of Acanthamoeba to Develop Targeted Strategies for Preventing Acanthamoeba Keratitis
Published on: September 20, 2024
10:56Complementary Use of Microscopic Techniques and Fluorescence Reading in Studying Cryptococcus-Amoeba Interactions
Published on: June 22, 2019